MktsMarkets

Oric Pharmaceuticals, Inc.
NASDAQ: ORICKey statistics
ORIC News
Stories mentioning ORIC from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 39,619 | 34,551 | 36,671 | 39,064 | 32,718 | 39,570 | 38,318 | 36,017 |
| Operating Income (Loss) | (39,619) | (34,551) | (36,671) | (39,064) | (32,718) | (39,570) | (38,318) | (36,017) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (35,767) | (30,505) | (32,587) | (36,355) | (30,021) | (36,307) | (34,566) | (31,963) |
| Earnings Per Share (Basic) | (0.34) | (0.35) | (0.33) | (0.47) | (0.42) | (0.52) | (0.49) | (0.45) |
| Earnings Per Share (Diluted) | (0.34) | (0.35) | (0.33) | (0.47) | (0.42) | (0.52) | (0.49) | (0.45) |
| Weighted Average Shares Outstanding (Basic) | 105,473 | 87,794 | 98,953 | 78,126 | 71,041 | 69,728 | 70,543 | 70,348 |
| Weighted Average Shares Outstanding (Diluted) | 105,473 | 87,794 | 98,953 | 78,126 | 71,041 | 69,728 | 70,543 | 70,348 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ORIC
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is a stock listed on the Nasdaq Stock Market under the ticker symbol ORIC. It last traded at $9.77 (Nov 3, 2026, 11:16 AM ET), up 7.7% on the day. That gives Oric Pharmaceuticals a market capitalisation of $946.3M.
Over the past 52 weeks ORIC has traded between $7.23 and $14.68.
For the quarter ended Mar 31, 2026 it reported a net loss of $35.8M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$35.8M |
| Dec 31, 2025 | — | -$30.5M |
| Sep 30, 2025 | — | -$32.6M |
| Jun 30, 2025 | — | -$36.4M |
From Oric Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…